Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Orthofix International NV (OFIX): Stephen Dubois Surges His Stake Amid Company’s Financial Statements Issues

As a new filing with the Securities and Exchange Commission showed, Camber Capital Management surged its exposure to Orthofix International NV (NASDAQ:OFIX). The fund managed by Stephen Dubois reported ownership of around 1.20 million shares of the company, versus 118,700 shares disclosed in the latest 13F filing. Camber’s stake amasses 6.5% of Orthofix’s common stock and is passive by nature.

Orthofix International NV (NASDAQ:OFIX)

Orthofix International NV (NASDAQ:OFIX) is a small cap medical device company that is engaged in developing and producing devices for the repair and derivative solutions, operating primarily in the spine and orthopedic markets. The stock of the company jumped by 36% since the beginning of the year amid several interesting developments. An interesting thing is that stock gained ground and investors still bought its stock despite some issues that Orthofix International NV (NASDAQ:OFIX) had with its financial statements. A couple of months ago, the company announced the delay of its financial results for the second quarter after restating its results for the previous periods. Nevertheless, the preliminary net sales of the company amount to $101.6 million for the second quarter, which is higher than $98 million reported for the same period of 2013. However, the restatement still impacted the company’s historical sales that have been slightly reduced.

Nevertheless, with the overall growth of the orthopedic industry, Orthofix International NV (NASDAQ:OFIX) might still be considered as a good investment. The orthopedic market is expected to reach around $4.0 billion over the next several years, while the growth rate is expected to reach over 3%. In addition, the industry of medical devices grew 7% year-to-date, with further growth could be expected in the future.

This could explain why Mr. Dubois and several other investors bet on Orthofix International NV (NASDAQ:OFIX). Conan Laughlin‘s North Tide Capital upped its exposure to the company by 60% over the second quarter and reported 1.80 million shares in its latest 13F. Mitchell Blutt‘s Consonance Capital Management increased its position by 34% during the same period to 1.47 million shares.

Analysts also seem to like Orthofix, the company’s consensus rating being ‘Overweight’ and the average target price reaching around $38.00, which is significantly above the current price of the stock.

Disclosure: none

Warren Buffett and BillionairesFree Report: Warren Buffett and 12 Billionaires Are Crazy About These 7 Stocks

Let Warren Buffett, David Einhorn, George Soros, and David Tepper WORK FOR YOU. If you want to beat the low cost index funds by an average of 6 percentage points per year look no further than Warren Buffett’s stock picks. That’s the margin Buffett’s stock picks outperformed the market since 2008. In this free report, Insider Monkey’s market beating research team identified 7 stocks Warren Buffett and 12 other billionaires are crazy about. CLICK HERE NOW for all the details.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.